Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Income from Continuing Operations (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 6 years of Income from Continuing Operations data on record, last reported at 63015000.0 in Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 36.79% year-over-year to 63015000.0; the TTM value through Dec 2025 reached 230762000.0, up 11.12%, while the annual FY2025 figure was 230762000.0, 11.12% up from the prior year.
  • Income from Continuing Operations reached 63015000.0 in Q4 2025 per MRVI's latest filing, down from 45057000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 156721000.0 in Q2 2022 and bottomed at 172455000.0 in Q3 2024.
  • Average Income from Continuing Operations over 5 years is 16581700.0, with a median of 13522500.0 recorded in 2023.
  • Peak YoY movement for Income from Continuing Operations: skyrocketed 9216.5% in 2021, then crashed 1582.49% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 127111000.0 in 2021, then crashed by 31.22% to 87429000.0 in 2022, then tumbled by 225.8% to 109982000.0 in 2023, then surged by 58.11% to 46067000.0 in 2024, then tumbled by 36.79% to 63015000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 63015000.0 in Q4 2025, 45057000.0 in Q3 2025, and 69837000.0 in Q2 2025.